As a peptide-based medication supplied in single-dose prefilled pens, tirzepatide requires careful storage to maintain its therapeutic effectiveness
Consult our medical team for suitability
Tirzepatide is a dual-action medication that targets two metabolic pathways: GIP and GLP-1 receptors
The drugs peripheral pathway of appetite control involves mechanisms outside of the central nervous system, such as boosting insulin levels in the pancreas
Individual providers may take a broader or narrower view within it, and a prescriber may still decline if the overall clinical picture does not support treatment
17: Ard J, Lee CJ, Gudzune K, Addison B, Lingvay I, Cao D, Mast CJ, Stefanski A, Falcon B, Mojdami D